« Back to Record
Citation APA

Bonnefoi, H., Litière, S., Piccart-Gebhart, M., MacGrogan, G., Fumoleau, P., Brain, E., Petit, T., Rouanet, P., Jassem, J., Moldovan, C., Bodmer, A., Zaman, K., Cufer, T., Campone, M., Luporsi, É. E., Malmström, P. O. P., Werutsky, G., Bogaerts, J., Bergh, J., & Cameron, D. A. (2014). Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: A landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. Annals of oncology, 25(6), 1128-1136. doi:10.1093/annonc/mdu118


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/194676

Bonnefoi, H., Litière, S., Piccart-Gebhart, M., MacGrogan, G., Fumoleau, P., Brain, E., Petit, T., Rouanet, P., Jassem, J., Moldovan, C., Bodmer, A., Zaman, K., Cufer, T., Campone, M., Luporsi, É. E., Malmström, P. O. P., Werutsky, G., Bogaerts, J., Bergh, J., & Cameron, D. A. (2014). Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: A landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. Annals of oncology, 25(6), 1128-1136. doi:10.1093/annonc/mdu118